Cognitive, Linguistic Deficits in Kindergarten Linked to Dyslexia Risk
via HealthDayWEDNESDAY, March 25, 2026 -- Cognitive-linguistic deficits in kindergarten are associated with an increased risk for early- and late-emerging dyslexia, according to a study published online March 24 in JAMA Network Open.
Rotem Yinon, Ph.D., from the Edmond J. Safra Brain Research Center for the Study of Learning Disabilities at the University of Haifa in Israel, and colleagues examined whether and to what extent deficits in four cognitive-linguistic domains in kindergarten estimate the risk for early- and late-emerging dyslexia (grades 1 and 4, respectively) in a prospective longitudinal cohort study. Measures, assessed in kindergarten, included phonological awareness, rapid automatized naming, letter knowledge, and morphological awareness.
The study included 515 Hebrew-speaking children (mean age, 5.9 years). The researchers found that kindergarten deficits in letter knowledge and phonological awareness were associated with increased risk for dyslexia in grade 1 (odds ratios, 4.75 and 4.17, respectively). Deficits in letter knowledge, morphological awareness, and rapid automatized naming were associated with an increased risk for dyslexia in grade 4 (odds ratios, 3.57, 2.56, and 2.39, respectively), independent of risk in grade 1 (odds ratio, 4.98).
"Pediatricians, as primary health care practitioners, are well positioned to support early identification and intervention, shifting dyslexia care from reactive to preventive and reducing long-term educational and psychosocial consequences," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-03-26 01:51
Read more
- Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide
- New Lyme Disease Vaccine Shows Strong Results in Trial
- Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
- Anxiety in Teens: What to Know
- FDA Approves Desmoda (desmopressin acetate) Oral Solution for Central Diabetes Insipidus
- Calquence Plus Venetoclax Approved in the US as First All-Oral, Fixed-Duration Combination for Patients with Chronic Lymphocytic Leukemia in the 1st-Line Setting
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions